Knowledge Center
Patent / Jan 24, 2019
Preparation of amorphous form of vilanterol trifenatate for the treatment of asthma and chronic obstructive pulmonary disease
Source:
WO 2019016512 20190124
The present invention relates to an amorphous form of vilanterol trifenatate, processes for its prepn. and its use in pharmaceutical formulations for the treatment of respiratory diseases, particularly for the treatment of asthma and chronic obstructive pulmonary disease.Ìý In particular, the invention relates to an amorphous form of vilanterol trifenatate, characterized by the x-ray powder diffraction (XRPD) pattern, obtained using copper K-α1 radiation.
Ìý
Ìý
Ìý
Also in the Knowledge Center
/ Jan 01, 1989
Rhodium hydrogenation catalysts particularly for stereoselective hydrogenation of methacycline to doxycycline
Read more
Scientific Article
/ Jan 01, 1989
Homogeneous catalytic system for hydrogenation of methylenetetracyclines and a process for the preparation of same
Read more
Scientific Article
Scientific Article